Bing Hou, Ph.D.

Executive Director of Drug Discovery
Antengene Corporation, China (People's Republic)

Poster(s):

• (T1130-11-61) A Computational Semi-mechanistic Pharmacology Model of ATG101, a PD-L1/4-1BB Bispecific Antibody for Treatment of Solid Tumors
  Tuesday, October 18, 2022

  11:30 AM – 12:30 PM ET